REGENERON PHARMACEUTICALS, INC.; INC.;UNIVERSITY HEALTH NETWORK (UHN);REGENERON PHARMACEUTICALS
发明人:
PURCELL NGAMBO, LISA ARLEEN,HIGGINS, SARAH, J.,KAIN, KEVIN C.
申请号：
CA2928852
公开号：
CA2928852A1
申请日:
2014.10.31
申请国别(地区):
CA
年份:
2015
代理人:
摘要：
The present invention provides methods for treating, preventing or reducing the severity of cerebral malaria. The methods of the present invention comprise administering to a subject in need thereof a therapeutically effective amount of a pharmaceutical composition comprising a modified angiopoietin molecule such as AngF1-Fc-F1.
